GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,399 | -70.2% | 16,728 | -56.8% | 0.00% | – |
| Q2 2023 | $212,817 | +292.8% | 38,694 | +207.1% | 0.00% | – |
| Q1 2023 | $54,180 | +10.3% | 12,600 | +0.8% | 0.00% | – |
| Q4 2022 | $49,101 | -56.9% | 12,494 | -41.8% | 0.00% | – |
| Q3 2022 | $114,000 | -68.2% | 21,482 | -60.7% | 0.00% | – |
| Q2 2022 | $359,000 | +0.8% | 54,639 | +12.7% | 0.00% | – |
| Q1 2022 | $356,000 | +75.4% | 48,488 | +68.9% | 0.00% | – |
| Q4 2021 | $203,000 | -6.0% | 28,706 | +233.8% | 0.00% | – |
| Q3 2021 | $216,000 | -58.1% | 8,600 | -55.2% | 0.00% | – |
| Q2 2021 | $516,000 | -63.7% | 19,197 | -61.6% | 0.00% | – |
| Q1 2021 | $1,422,000 | +244.3% | 49,983 | +274.3% | 0.00% | – |
| Q3 2020 | $413,000 | -96.4% | 13,353 | -97.5% | 0.00% | -100.0% |
| Q2 2020 | $11,405,000 | – | 543,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $32,535,983 | 3.92% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $4,018,570 | 0.79% |
| Artal Group S.A. | 2,814,191 | $11,060 | 0.62% |
| SVB FINANCIAL GROUP | 52,920 | $207,976 | 0.57% |
| PFM Health Sciences, LP | 2,903,192 | $11,409,545 | 0.41% |
| Cheyne Capital Management (UK) LLP | 51,126 | $200,925 | 0.35% |
| HighVista Strategies LLC | 138,880 | $545,798 | 0.32% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,005,691 | 0.25% |
| SECTORAL ASSET MANAGEMENT INC | 273,787 | $1,075,983 | 0.21% |
| Yiheng Capital Management, L.P. | 1,186,295 | $4,662,139 | 0.21% |